Well now that you've let out the secret, no one is going to buy and keep the price green. ;-(
This isn't the same as AMZN making book recommendations. FB was filtering the news to create either a positive or negative mood. If the gov't were doing this, and they might be, you'd be plenty upset.
Last week shares went as high as 4.99 on "good news." Well, that didn't last. Down 5% today and we're right back to where we were 2 weeks ago. Even a turd floats once in a while.
Problem is that if GM is placing the ad, I know it is GM and it is an ad. In this case, FB is leading me to believe that I'm getting unbiased news. The upside to this story is that we now know not to trust anything that comes out of FB.
FB was manipulating the news feed. Think of it as getting a newspaper with all of the news that either good or bad, from your perspective, being cut out. This was basically how the newspapers of WWII Germany worked; no news that would have questioned the war was permitted to be printed.
While AMZN, etc. look at your preferences in deciding what to advertise to you, they don't try to change your mood or attitude toward a specific topic.
Between GOOG, AMZN, and FB, computers know me better than my friends. Who would you like to buy a birthday gift for you? The computer or your friend? Best of both: I'd like the computer to make the decision, but make it look like my friend was the thoughtful one.
I know this is an investment board, but I suspect that those who in invest in FB are hoping that there isn't a backlash on this movement towards a new machine age.
Next thing you know, someone in gov't is going to work with FB to create the right mood before an election. Will it get your attention then?
No, I think they are awaiting therapy development news and most importantly, some positive comments from the FDA. The CEO shouldn't spend his time trying to prop up the price. If he did, that might seem like desperation and shorts would just sell more.
Selling their shares? I have no idea of what you are asking.
Share price is dropping because the trend is down and no one who wants to be long is willing to buy until there is a reversal in price. As long as there isn't any news to bring in buyers, the slide continues.
that made this sort of announcement regarding patented markers of prostate cancel would gain at least $50 million of market cap. For ROSG, 20 cent gain is about $2 million.
Unfortunately, the trend has been down for so long that any bump is seen as an opportunity to sell and reduce losses. It happens every time there is "positive news." Until they announce a license with actual dollar terms, I see no reason for a change in this pattern. I've been wrong before; I hope I'm wrong again.
This is from today's PR regarding indicators of prostate cancer. It is the first time I've head this from Mr. Berlin and perhaps he's finally seeing the need to begin to pay for R & D with money generated from sources other than secondaries.
I signed up years ago and tried to use it to communicate with business associates. Mixed results; haven't used it since.